Cornell researchers have discovered a way to open one of the major barriers to the brain, called the blood brain barrier (BBB), which prevents the entry of therapies to treat brain disorders, such as Alzheimer’s disease.
The finding also has implications for treating all chemotherapy-resistant cancers.
For a century now, a major challenge in the treatment of diseases of the brain has been discovering how to safely deliver drugs across the BBB. The BBB is composed of a layer of specialized cells, called endothelial cells, which line the brain’s blood vessels and safeguard the brain from unwanted substances. These cells also selectively allow entry of molecules needed for brain function, such as amino acids, oxygen, glucose and water.
Cornell researchers report that an FDA-approved drug called Lexiscan, which is used in heart imaging, activates receptors – called adenosine receptors – that are expressed on these BBB cells.
“We can open the BBB for a brief window of time, long enough to deliver therapies to the brain, but not too long so as to harm the brain. We hope in the future, this will be used to treat many types of neurological disorders,” said Margaret Bynoe, associate professor in the Department of Microbiology and Immunology in Cornell’s College of Veterinary Medicine. Bynoe is senior author of the study appearing April 4 in The Journal of Clinical Investigation. Do-Geun Kim, now a postdoctoral associate in Bynoe’s lab, is the paper’s first author.
The researchers were able to deliver chemotherapy drugs into the brains of mice, as well as large molecules, like an antibody that binds to Alzheimer’s disease plaques, according to the paper.
To test whether this drug delivery system has application to the human BBB, the lab engineered a BBB model using human primary brain endothelial cells. They observed that Lexiscan opened the engineered BBB in a manner similar to its actions in mice.
Bynoe and Kim discovered that a protein called P-glycoprotein is highly expressed on brain endothelial cells and blocks the entry of most drugs delivered to the brain. Lexiscan acts on one of the adenosine receptors expressed on BBB endothelial cells specifically activating them. They showed that Lexiscan down-regulates P-glycoprotein expression and function on the BBB endothelial cells. It acts like a switch that can be turned on and off in a time dependent manner, which provides a measure of safety for the patient.
“We demonstrated that down-modulation of P-glycoprotein function coincides exquisitely with chemotherapeutic drug accumulation” in the brains of mice and across an engineered BBB using human endothelial cells, Bynoe said. “The amount of chemotherapeutic drugs that accumulated in the brain was significant.”
In addition to P-glycoprotein’s role in inhibiting foreign substances from penetrating the BBB, the protein is also expressed by many different types of cancers and makes these cancers resistant to chemotherapy.
“This finding has significant implications beyond modulation of the BBB,” Bynoe said. “It suggests that in the future, we may be able to modulate adenosine receptors to regulate P-glycoprotein in the treatment of cancer cells resistant to chemotherapy.”
Because Lexiscan is an FDA-approved drug, ”the potential for a breakthrough in drug delivery systems for diseases such as Alzheimer’s disease, Parkinson’s disease, autism, brain tumors and chemotherapy-resistant cancers is not far off,” Bynoe said.
Another advantage is that these molecules (adenosine receptors and P-glycoprotein are naturally expressed in mammals. “We don’t have to knock out a gene or insert one for a therapy to work,” Bynoe said.
Learn more: Breakthrough allows drug delivery for brain diseases, cancers
The Latest on: Blood brain barrier
[google_news title=”” keyword=”blood brain barrier” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Blood brain barrier
- Doctor gives advice for switching allergy medications this springon April 27, 2024 at 3:01 am
With pollen counts high in Ohio and allergy season in full swing, you might be reaching for a new kind of antihistamine for relief. Itchiness is one symptom that you could have after stopping ...
- I’m a nutritionist – here are the best foods to eat for a healthy brainon April 26, 2024 at 10:01 pm
New research indicates that diet can have a significant impact on brain health. Here's what to eat to keep your grey matter happy ...
- New study finds that brain structure changes cyclically throughout the menstrual cycleon April 23, 2024 at 1:15 pm
In October 2023, a research study out of the University of California, Santa Barbara (UCSB) found that the entirety of womens' brain structure actually fluctuates throughout the menstrual cycle as ...
- Nanoparticles Deliver Drugs Directly Across the Blood-Brain Barrieron April 22, 2024 at 9:02 am
This process results in the formation of the protein/biomolecular corona. This composition enhances the nanocrystals’ ability to traverse the blood-brain barrier; our research shows that these gold ...
- How microplastics can travel from food to vital organs — including the brain, new study findson April 22, 2024 at 8:57 am
On Earth Day, here’s a look at how microplastics were able to migrate from food and drink into the organs of research mice — and the implications for humans.
- Eisai, BioArctic to develop new drug for Alzheimer’s that can cross blood-brain barrieron April 22, 2024 at 6:41 am
Eisai and BioArctic — the companies behind the first Alzheimer’s drug proven to slow disease progression — are inking another research partnership in the disease, this time utilizing the Swedish ...
- Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injuryon April 22, 2024 at 1:05 am
Traumatic brain injuries come with an amplified risk for developing dementia, but a new therapeutic target and a potential immunotherapy have been identified.
- A new therapeutic target for traumatic brain injuryon April 19, 2024 at 9:39 am
For the roughly 1.5 million Americans per year who survive a traumatic brain injury, health outcomes vary widely. Not only can these injuries lead to a loss of coordination, depression, impulsivity, ...
- Microplastics can travel to the brain and other vital organs after ingestion, new study findson April 18, 2024 at 5:05 am
In testing, researchers discovered microplastics in the brains and other vital organs of mice — and clues into how plastics can harm humans.
- Discovery of Long COVID Brain Fog Cause Hints at Future Treatmentson April 15, 2024 at 6:53 am
Recent findings that leaky blood vessels in the brain and heightened immune activity are key drivers of long COVID brain fog provide insights into possible targets for treatment.
via Bing News